ACRO's CRO Forum Will Liaise with TransCelerate

March 9, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

The Association of Clinical Research Organizations held its inaugural meeting of the CRO Forum. The Forum was established in October 2014 as the primary vehicle for interaction between the CRO industry and TransCelerate BioPharma.

The Association of Clinical Research Organizations held its inaugural meeting of the CRO Forum. The Forum was established in October 2014 as the primary vehicle for interaction between the CRO industry and TransCelerate BioPharma. ACRO and TransCelerate have mutually agreed to initially establish liaison relationships between four TransCelerate workstreams: risk-based monitoring; shared site qualification and training; common protocol template; and quality management system. 

The Forum elected as its first Chairman Dr. Alan Metz, Senior Vice President and Managing Director, Strategic Partnerships, at Quintiles. As Vice Chair, the Forum elected Amy Kissam, Executive Director, Global Operational Management, at INC Research. In addition, the CRO Forum selected senior subject matter experts to serve as liaisons to each of the workstreams, and will be supported by working groups consisting of subject matter experts from across the Forum membership.

 

Read the full release here.

Related Content:

News